🔥 We have been featured on Shark Tank India.Episode 13

🔥 We have been featured on Shark Tank India

logologo
Search anything
Ctrl+K
gift
arrow
WhatsApp Icon

TruAlt Bioenergy: Navigating Growth and Strategic Expansion in India's Bioenergy Sector

TRUALT

TruAlt Bioenergy Ltd

TRUALT

Ask AI

Ask AI

TruAlt Bioenergy Limited, a prominent player in India's biofuels landscape, has released its financial and operational performance for the quarter and nine months ended December 31, 2025 (Q3 FY26). The results highlight a period of significant strategic expansion and operational consolidation, even as the company navigates the financial implications of its ambitious growth initiatives. The consolidated total income for Q3 FY26 surged by an impressive 69.75% quarter-on-quarter to ₹730.86 crore. For the nine-month period, consolidated total income grew by 13.28% to ₹1,187.05 crore, underscoring the company's robust top-line performance. However, this growth was accompanied by increased finance costs and depreciation, impacting profitability metrics like Profit Before Tax (PBT) and Profit After Tax (PAT) in the short term.

Strategic Investments Fueling Future Growth

The company's Managing Director, Mr. Vijay Nirani, emphasized that the third quarter reflects meaningful progress in strengthening TruAlt Bioenergy's operating foundation. The core ethanol segment, which remains the company's largest revenue contributor, saw its planned capital expenditure for grain-based integration fully commissioned. Despite a delayed sugar crushing season in Karnataka, which limited effective operating days in Q3, four of the five ethanol plants operated at over 95% capacity utilization on operating days. With Unit 5 now fully operational, TruAlt Bioenergy is poised to achieve a monthly ethanol production of approximately 5.5 to 6 crore litres, transitioning from a seasonal business to a near year-round, multi-feed biofuels enterprise.

Financial Performance Snapshot (Consolidated)

Particulars9M FY26 (₹ Crore)9M FY25 (₹ Crore)Variance (%)
Total Income1187.051047.8513.28
PBT46.2548.54(4.72)
PAT35.9234.942.79
EBITDA170.99155.4310.01

Diversification into New Green Energy Verticals

TruAlt Bioenergy is strategically expanding its footprint across various green energy verticals. The Compressed Biogas (CBG) segment delivered a strong performance, recording an EBITDA margin of 63% and a PAT margin of 43% for the nine months ended December 31, 2025. The company plans to develop 24 greenfield CBG units over the next two to three years through joint ventures with Sumitomo Corporation and GAIL, with four new plants scheduled for commissioning by July 2026. This expansion is significantly bolstered by policy momentum, including excise duty exemptions and the CBG Blending Obligation.

Another major strategic move is the entry into the Sustainable Aviation Fuel (SAF) segment. TruAlt Bioenergy has progressed with a technology licensing agreement with Honeywell UOP for a proposed 100 million litres per annum SAF facility in Andhra Pradesh, with a proposed investment of ₹2,250 crore. The company is also positive about receiving ₹150 crore in viability gap funding under the PM JI-VAN scheme, positioning it as an early mover in this critical decarbonization pathway for aviation.

Segment-wise Revenue Contribution (9M FY26 Consolidated)

SegmentRevenue (₹ Crore)Percentage (%)
Ethanol1108.1393.35
CBG30.972.61
Retail Fuel Network48.194.06

Building a Robust Downstream Presence

In the biofuel retail segment, TruAlt Bioenergy has rapidly commissioned seven retail outlets within six months, following the receipt of its oil marketing company license. With four additional stations under development, the company aims to scale to approximately 75 outlets by FY27. This downstream integration enhances customer access and margin capture, aligning with the anticipated adoption of flex-fuel in India. Furthermore, the company continues to explore value-enhancing opportunities through co-products like Distillers Dried Grains with Solubles (DDGS) and green CO2, reinforcing its integrated operating model and focus on resource efficiency.

Outlook and Investor Confidence

While the current quarter's profitability was impacted by transitional operating factors related to its expansion, the commissioning of Unit 5 and ongoing strategic initiatives position TruAlt Bioenergy for sustained performance and improved visibility going forward. The management's clear focus on disciplined scaling, strategic investments, and leveraging government support for green energy initiatives instills confidence. TruAlt Bioenergy is actively shaping India's green energy transition, aiming to deliver consistent financial performance and create enduring value for its shareholders by participating in the emerging business opportunities in the biofuel space.

Frequently Asked Questions

For Q3 FY26, TruAlt Bioenergy reported a consolidated total income of ₹730.86 crore, marking a 69.75% quarter-on-quarter growth. For the nine months ended December 31, 2025, consolidated total income was ₹1,187.05 crore, an increase of 13.28% year-on-year. However, profitability was impacted by higher finance costs and depreciation due to capacity expansion.
TruAlt Bioenergy has fully commissioned its grain-based integration capex, with all five ethanol plants now operational. The company aims for a monthly ethanol production of approximately 5.5 to 6 crore litres, transitioning to a near year-round, multi-feed biofuels enterprise. The total installed ethanol capacity is 2,000 KLPD, with 1,300 KLPD having dual-feed integration.
TruAlt Bioenergy plans to develop 24 greenfield CBG units over the next two to three years through joint ventures with Sumitomo Corporation and GAIL. Four new plants are scheduled for commissioning by July 2026. The CBG segment has shown strong performance, recording an EBITDA margin of 63% and a PAT margin of 43% for the nine months ended December 31, 2025.
The company has entered the SAF segment with a technology licensing agreement with Honeywell UOP for a proposed 100 million litres per annum SAF facility in Andhra Pradesh. A ₹2,250 crore investment is planned, and TruAlt Bioenergy is positive about receiving ₹150 crore in viability gap funding under the PM JI-VAN scheme. Revenues from SAF are expected to commence in FY28.
TruAlt Bioenergy has commissioned seven retail fuel outlets and has four more under development. The company aims to scale its retail network to approximately 75 outlets by FY27 as part of a 100-outlet rollout plan. This expansion is intended to enhance downstream presence and capitalize on the adoption of flex-fuel in India.
The company produces value-added co-products such as Dried Distillers Grains with Solubles (DDGS) and green CO2. DDGS production commenced from Q3 FY26, contributing to incremental revenue and strengthening EBITDA margins.
The company benefits from policy tailwinds for CBG, including excise duty exemptions, the CBG Blending Obligation, and Market Development Assistance (MDA). For SAF, it is pursuing viability gap funding under the PM JI-VAN scheme and state-level incentives.

A NOTE FROM THE FOUNDER

Hey, I'm Aaditya, founder of Multibagg AI. If you enjoyed reading this article, you've only seen a small part of what's possible with Multibagg AI. Here's what you can do next:

It's all about thinking better as an investor. Welcome to a smarter way of doing stock market research.